Theriva Biologics, Inc. TOVX

Set alert

Price alert · TOVX

All alert types
0.18 USD +0.01 +7.92%

At close

0.19 0.00 +0.60%

Pre-market · Nov 3, 6:24 AM ET

Bid
0.19 × 300
Ask
0.19 × 3,400
0.1361 Day range 0.1904
0.1361 52-week range 0.49
YTD
-12.38%
1 year
-40.65%
Open
0.15
Prev close
0.1705
Mkt cap
8.44M
Vol
91.20M
Avg vol
520.48K
EPS
0.73
P/E
0.25
Div yield
0.00%
More statistics
Low
0.1361
High
0.1904
Forward P/E
-0.07
Beta
1.34
Short ratio
0.03
Inst. own
21.21%
Dividend
0.00
Ex-div date
50-d avg
1.44
200-d avg
5.63
1y target
90.50

MAX chart

Chart tools
Interval

Signals (69)
NameDateAgo
RSI: OversoldOct 1, 20261 month ago
SMA: BearishSep 1, 20262 months ago
SMA: BullishAug 1, 20263 months ago
RSI: OversoldJun 1, 20265 months ago
SMA: BearishMay 1, 20266 months ago
SMA: BullishApr 1, 20267 months ago
RSI: OversoldMay 1, 20251 year ago
RSI: OversoldSep 1, 20242 years ago
SMA: BearishJul 1, 20233 years ago
SMA: BullishJun 1, 20233 years ago
RSI: OversoldOct 1, 20224 years ago
SMA: BearishAug 1, 20215 years ago
SMA: BearishJul 1, 20215 years ago
SMA: BullishJun 1, 20215 years ago
SMA: BearishMay 1, 20215 years ago
SMA: BullishJan 1, 20215 years ago
SMA: BullishJan 1, 20215 years ago
SMA: BearishSep 1, 20206 years ago
SMA: BullishJun 1, 20206 years ago
SMA: BearishFeb 1, 20206 years ago

Newest 20 of 69.

Analyst view

Consensus: none

Price target (mean) 90.50 +49084.8% upside
Target (low)
6.00
Target (mean)
90.50
Target (high)
175.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 2

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

TOVX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-5.50-5.50 – -5.50-8.25+33.3%00.0%1
Next quarter0.000.00 – 0.00-7.500.0%00.0%0
Current year-23.75-23.75 – -23.75-28.50+16.7%00.0%1
Next year0.000.00 – 0.000.000.0%00.0%0

Upgrades and downgrades

The latest rating changes

TOVX analyst upgrades and downgrades
DateFirmActionFromTo
Nov 13, 2024Maxim GroupMaintainedBuyBuy